| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0049-3848(97)00222-3 |
| P698 | PubMed publication ID | 9361364 |
| P2093 | author name string | Mandalaki T | |
| Hatzizacharias A | |||
| Krespi P | |||
| Makris TK | |||
| Tsoukala C | |||
| Gialeraki A | |||
| Papargyriou J | |||
| Votteas V | |||
| P2860 | cites work | Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias | Q29616292 |
| The pathogenesis of atherosclerosis (first of two parts) | Q33492794 | ||
| Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study | Q33612628 | ||
| The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review | Q35450766 | ||
| Atherosclerosis and the coagulation system | Q38713518 | ||
| Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial | Q39628863 | ||
| The pathogenesis of atherosclerosis--an update | Q39726917 | ||
| Prospective study of endogenous tissue plasminogen activator and risk of stroke | Q41036094 | ||
| Hypo-fibrinolysis in patients with hypertension and elevated cholesterol | Q41162776 | ||
| The effects of pressure-induced cardiac hypertrophy on the functional capacity of the coronary circulation | Q43454051 | ||
| Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension. | Q51600057 | ||
| Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. | Q54252017 | ||
| Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. | Q54373170 | ||
| Evidence of decreased fibrinolytic activity in hypertensive premenopausal women | Q67584661 | ||
| Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease | Q68502564 | ||
| Von Willebrand factor and cardiovascular risk | Q68797736 | ||
| Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects | Q69191536 | ||
| Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction | Q69901572 | ||
| Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction | Q69973450 | ||
| ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography | Q70558786 | ||
| Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 | ||
| Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation | Q72671656 | ||
| Microalbuminuria and endothelial dysfunction in essential hypertension | Q72682381 | ||
| Plasma levels of beta-thromboglobulin and factor VIII-related antigen in diabetic children and adults | Q72696556 | ||
| [Rapid physiological coagulation method in determination of fibrinogen] | Q74515389 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 99-107 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | Haemostasis balance disorders in patients with essential hypertension | |
| P478 | volume | 88 |
| Q74343382 | A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension |
| Q44165707 | Acute effects of transdermal 17beta-estradiol on hemostatic variables after 24-hour treatment |
| Q37447635 | Blood Pressure and Fibrinogen Responses to Mental Stress as Predictors of Incident Hypertension over an 8-Year Period |
| Q33704612 | Clinical implications of elevated PAI-1 revisited: multiple arterial thrombosis in a patient with essential thrombocythemia and elevated plasminogen activator inhibitor-1 (PAI-1) levels: a case report and review of the literature |
| Q43619875 | Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial |
| Q46431030 | Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors |
| Q39600091 | Hemostasis parameters disturbances in healthy individuals with prehypertension |
| Q87428056 | Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: the effect of treatment with an angiotensin II receptor blocker |
| Q36082001 | Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction |
| Q39773947 | Masked hypertension unfavourably affects haemostasis parameters. |
| Q79329776 | Parental history of hypertension is associated with coagulation-fibrinolytic balance disorders |
| Q32056571 | Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects |
| Q37119116 | The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients |
Search more.